However, in the multivariate analysis only a high percentage of PD-1+CD3+CD4+, PD-L1+CD3+, PD-L1+CD3+CD8+ and PD-L2+CD3+ cells were significantly associated with reduced OS in NSCLC patients. This evidence concerns the gene CD4 and non-small cell lung carcinoma.